Used primarily in pharmaceutical research as a key intermediate in the synthesis of selective serotonin reuptake inhibitors (SSRIs) and antipsychotic agents. Its structural framework supports binding to central nervous system receptors, making it valuable in developing drugs for depression, anxiety, and schizophrenia. Also explored in the design of dopamine and sigma receptor ligands for neurological disorder therapies. Due to its bioactive potential, it serves as a scaffold in medicinal chemistry for optimizing drug candidates with improved brain penetration and receptor specificity.